CO-OLMESARTAN AMLO Spirig HC 40/10/25mg 30 pce

7680674470090 CH-67447 C09DX03 02.07.2.

Reimbursement limitations:

COOLMAMLSPIR

Le traitement combiné d’une association fixe d’olmésartan-amlodipine ou d’olmésartan-amlodipine-hydrochlorothiazide et d'un antagoniste du calcium I.T. …

CO-OLMESARTAN AMLO Spirig HC 40/10/25mg 30 pce
CO-OLMESARTAN AMLO Spirig HC 40/10/25mg 30 pce
1 / 2
google

Details

Product number
6744705
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
olmesartanum medoxomilum 40 mg, amlodipinum 10 mg ut amlodipini besilas, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, lactosum monohydricum 205.13 mg, Überzug: hypromellosum, lactosum monohydricum 3.92 mg, macrogolum 4000, E 171, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto.

Articles (1)

Co-Olmesartan Amlo Spirig HC 40 mg/10 mg/25 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/09/2025
Patient information leaflet
Français
24/09/2025
Patient information leaflet
Italien
24/09/2025
Professional SmPC
Allemand
24/09/2025
Professional SmPC
Français
24/09/2025
Professional SmPC
Italien
24/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
205.13 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
3.92 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 40.25
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/01/2021

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
67447
Drug name
Co-Olmesartan Amlo Spirig HC, Filmtabletten
Galenic form
FILM
ATC Code
C09DX03
Authorization status
Z
Dispensation category
B
First authorization
22/04/2020
Authorization expiration date
31/12/9999
IT number
02.07.2.
Domain
Human medicine
Field of application
Hypertonie

Packaging details

Description (FR)
CO-OLMESARTAN AMLO Spirig HC 40/10/25mg 30 pce
Description (DE)
CO-OLMESARTAN AMLO Spirig HC 40/10/25mg 30 Stk
Market launch
22/04/2020
Narcotic (BTM)
No

Original drug

Sevikar HCT, Filmtabletten
GTIN: 7680615190018
CHF 35.40
View original

Other packaging sizes

CO-OLMESARTAN AMLO Spirig HC 20/5/12.5mg 30 pce
30 TABL
GTIN: 7680674470014
View
CO-OLMESARTAN AMLO Spirig HC 20/5/12.5mg 100 pce
100 TABL
GTIN: 7680674470021
View
CO-OLMESARTAN AMLO Spirig HC 40/5/12.5mg 30 pce
30 TABL
GTIN: 7680674470038
View
CO-OLMESARTAN AMLO Spirig HC 40/5/12.5mg 100 pce
100 TABL
GTIN: 7680674470045
View
CO-OLMESARTAN AMLO Spirig HC 40/5/25mg 30 pce
30 TABL
GTIN: 7680674470052
View
CO-OLMESARTAN AMLO Spirig HC 40/5/25mg 100 pce
100 TABL
GTIN: 7680674470069
View
CO-OLMESARTAN AMLO Spirig HC 40/10/12.5mg 30 pce
30 TABL
GTIN: 7680674470076
View
CO-OLMESARTAN AMLO Spirig HC 40/10/12.5mg 100 pce
100 TABL
GTIN: 7680674470083
View
CO-OLMESARTAN AMLO Spirig HC 40/10/25mg 100 pce
100 TABL
GTIN: 7680674470106
View